Inova's program is the only fully-integrated pulmonary hypertension program in the region and builds on the national reputation of Inova's Advanced Lung Disease and Transplant Programs. Under the directorship of Oksana A. Shlobin, MD, FCCP, a care team comprised of numerous medical and support experts meets weekly to review and establish treatment plans for individual patients. Our team members present at pulmonary conferences throughout the world including ISHLT, ATS, Chest, ERS, PHA annual meetings and regional programs.
Contact Us to Schedule an Appointment
Dr. Shlobin serves on the Oversight Committee and the Scientific Leadership Council for the Pulmonary Hypertension Association (PHA) and is a member of the Pulmonary Vascular Disease Network Committee for the American College of Chest Physicians (CHEST).
Dr. Nathan had the honor of participating in the most recent World Symposium on Pulmonary Hypertension in Nice, France in 2018, where he served as the task force co-chair for the Group 3 PH committee.
Dr. King has recently been selected to serve as a member of the Guidelines Oversight Committee for the ACCP. Dr. King also serves as the chair of the data safety monitoring board for a NIH-sponsored study on pulmonary hypertension.
Surgical Director, CTEPH Program and Heart and Lung Transplant Program
Medical Director, Heart Transplant Program
Director, Infiltrative Cardiomyopathy Program
Pulmonary Disease Specialists
PH Nurse Coordinators
Johanna Coughlin, RN
Alicia Echols, RN
Shanna Guzman, RN
Inpatient Care Team
Michelle Kopp, PA
Lauren M. Marinak, NP
Nikki Sisserson, PA
Morgan Wahl, RN